Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co – authored, adding:
“Here’s the important data from the French cohort of our Santorini study.
The message is the same.
Countries using combination therapy do better than those using statin based monotherapy like the UK and France .
Time to shift the needle to combination therapies from FDC to reduce pill burden especially.”
Title: Lipid management in high cardiovascular risk patients in France: a comparison with rest of Europe patients from 1-year follow-up of Santorini
Authors: Jean Ferrières, Kausik K. Ray, Alberico L. Catapano, Radhouan Allouche, Christian Becker, Aurélie Bardet, Michel Farnier
Read the Full Article on Frontiers in Cardiovascular Medicine
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association
-
Jul 2, 2026, 16:22Shinto Francis Thekkudan: Delegates Visiting our BMT and Hematology Department from Kazhakstan
-
Jul 2, 2026, 16:13William Aird: When Deciding whether an Adult Patient is Anemic, Which Do You Usually Use?